Sangrix Cancels 66,668 Shares in Investor Redemption
The cancelled shares were returned to authorized but unissued share capital, leaving 1,881,935 Class A ordinary shares outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SANGRIX INC. (SGRX) reports that investors exercised a contractual redemption right for 66,668 Class A ordinary shares, representing all of their respective unsold shares. The shares were cancelled on September 22, 2026 and returned to authorized but unissued share capital. Following the cancellation, 1,881,935 Class A ordinary shares were issued and outstanding.
The agreements allowed investors who had not sold all their shares within 12 months after August 11, 2025 to elect to redeem a portion of the DOGE paid, by written notice within 15 business days after that anniversary. All investors delivered notices on August 20, 2026. The redemption was described as involving the return to the Company of 30 million DOGE, representing 100% of the DOGE originally paid; the original aggregate purchase price was $6,000,000. The shares were issued in a private placement, and no warrants were issued under the agreements.
Key Figures
Key Terms
redemption right financial
private placement regulatory
redeemable amount of DOGE financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the deadline for SGRX investors to exercise the DOGE redemption right?
AI-generated analysis. How Rhea-AI works. Not financial advice.